Tarun Singhal is a Neurology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 134 publications with 2,086 citations (h-index 23); ClinicalTrials.gov lists 8 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Francis St
Department Of Neurology, Bwh
Boston, MA 021156110
Telephone
617-732-5500Registry record last updated 30 Oct 2014.
Clinical trials
- Glucose Consumption in MS Using [F-18]FDG-PET
Sponsor: Brigham and Women's Hospital
- Assessment of Synaptic Density in MS
Sponsor: Brigham and Women's Hospital
- Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients
Sponsor: Brigham and Women's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20252 payments
- EMD Serono, Inc.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
61.8%Potassium Channel Blocker12.6%Dalfampridine Er84%Ampyra16%Part D<11 patientsCentral Nervous System Stimulant11%Methylphenidate Hcl39%Dextroamphetamine-Amphetamine26%Dextroamphetamine-Amphet Er15%Methylphenidate Er10%Dextroamphetamine Sulfate10%Part D<11 patients+ 6 more classes in this area
Musculoskeletal
16.8%gamma-Aminobutyric Acid-ergic Agonist11.3%Baclofen100%Part D≥29 patientsCentral alpha-2 Adrenergic Agonist5.5%Tizanidine Hcl100%Part D≥15 patientsCancer & immunology
15.3%CD20-directed Cytolytic Antibody6.7%Kesimpta Pen100%Part D<11 patientsOther immunostimulants4.8%Copaxone77%Glatopa24%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer’s Disease Dementia
Clinical Nuclear Medicine
2025 - Glial Activity Load on PET Reveals Persistent “Smoldering” Inflammation in MS Despite Disease-Modifying Treatment
Clinical Nuclear Medicine
2024 - Stigma in Multiple Sclerosis: A Narrative Review of Current Concepts, Measures, and Findings
International Journal of MS Care
2024 - State-of-the-art imaging of neuromodulatory subcortical systems in aging and Alzheimer’s disease: Challenges and opportunities
Neuroscience & Biobehavioral Reviews
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”